Immunique
Redefining Healthy Longevity Through Precision Immune Resilience
Seongnam, South Korea · Founded 2021
- Headquarters
- Seongnam
- Founded
- 2021
- Business Model
- B2B
- Website
- immunique.co.kr
About
IMMUNIQUE is a South Korean biotech company redefining healthy longevity through precision immune resilience. It develops three core platforms: PRIME-NK, a feeder-free NK cell production platform aimed at supportive recovery care after cancer treatment; IMMUNOKINE, AI-designed cytokine-like peptides that selectively modulate immune cell function; and AUTO-Treg, a patient-specific autologous regulatory T-cell platform for immune tolerance in autoimmune disease.
Summary
Immunique is a Biotech company based in Seongnam, South Korea, founded in 2021.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunique"><img src="https://indexed.vc/api/badge/company/immunique" alt="Immunique on Indexed.vc" width="260" height="76" /></a>